THE EFFECTS OF BIOLOGIC AND SMALL MOLECULE INHIBITOR THERAPY ON THE MUCOSAL IMMUNE SYSTEM IN ULCERATIVE COLITIS

被引：1
作者：
Briggs, Kristi
Tam, Ada
Housseau, Franck
Melia, Joanna
Pardoll, Drew
机构：
来源：
INFLAMMATORY BOWEL DISEASES | 2023年 / 29卷
关键词：
D O I：
10.1093/ibd/izac247.083
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S45 / S45
页数：1
相关论文
共 50 条
[31]   Small molecule oral targeted therapies in ulcerative colitis [J].
Shivaji, Uday N. ;
Nardone, Olga Maria ;
Cannatelli, Rosanna ;
Smith, Samuel Cl ;
Ghosh, Subrata ;
Iacucci, Marietta .
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2020, 5 (09) :850-861
[32]   Editorial: Is vedolizumab the preferred biologic therapy for biologic-naive patients with ulcerative colitis? [J].
Yamamoto, Takayuki .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (05) :546-547
[33]   Biologic and Small Molecule Therapy in Atopic Dermatitis [J].
Shergill, Mahek ;
Bajwa, Barinder ;
Yilmaz, Orhan ;
Tailor, Karishma ;
Bouadi, Naila ;
Mukovozov, Ilya .
BIOMEDICINES, 2024, 12 (08)
[34]   DEFICIENCY OF A MUCOSAL TRYPSIN-INHIBITOR IN PATIENTS WITH ULCERATIVE-COLITIS [J].
PLAYFORD, RJ ;
FREEMAN, T ;
QUINN, C ;
CALAM, J .
GUT, 1990, 31 (10) :A1166-A1166
[35]   Ulcerative colitis exacerbation after the onset of immune checkpoint inhibitor related colitis [J].
Kayashima, Atsuto ;
Shimozaki, Keitaro ;
Hirata, Kenro ;
Mutaguchi, Makoto ;
Takabayashi, Kaoru ;
Hayashi, Yuichiro ;
Hosoe, Naoki ;
Ogata, Haruhiko ;
Sujino, Tomohisa ;
Kanai, Takanori .
CLINICAL JOURNAL OF GASTROENTEROLOGY, 2021, 14 (01) :152-158
[36]   Aggravated mucosal and immune damage in a mouse model of ulcerative colitis with stress [J].
Gong, Yanxia ;
Niu, Wei ;
Tang, Yanping ;
Zhang, Qingyu ;
Liu, Simiao ;
Liu, Xi ;
Wang, Xiao ;
Xu, Yang .
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 17 (03) :2341-2348
[37]   Immune Checkpoint Inhibitor-Induced Colitis or Ulcerative Colitis: A Histopathological Dilemma [J].
Bodek, Daniel ;
Everwine, Matthew ;
Mapow, Beth ;
Foster, Jonathan ;
Blair, Brian .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 :S1195-S1196
[38]   Ulcerative colitis exacerbation after the onset of immune checkpoint inhibitor related colitis [J].
Atsuto Kayashima ;
Keitaro Shimozaki ;
Kenro Hirata ;
Makoto Mutaguchi ;
Kaoru Takabayashi ;
Yuichiro Hayashi ;
Naoki Hosoe ;
Haruhiko Ogata ;
Tomohisa Sujino ;
Takanori Kanai .
Clinical Journal of Gastroenterology, 2021, 14 :152-158
[39]   IMMUNE SYSTEM DISORDER IN PATIENTS WITH ULCERATIVE COLITIS [J].
Yegorova, S. U. ;
Kudryavceva, V. Y. .
VISNYK OF DNIPROPETROVSK UNIVERSITY-BIOLOGY ECOLOGY, 2009, 17 (01) :65-69
[40]   Ulcerative Colitis Therapy: Vedolizumab as a First-line Biologic Agent? [J].
Metzger, Leandra .
ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2022, 60 (03) :274-276
12345